Key result
Transcatheter tricuspid interventions, particularly TEER, provide a valuable treatment alternative for high-risk TR.
Why the study?
Tricuspid regurgitation is a frequent, undertreated condition linked to poor outcomes, for which transcatheter interventions have emerged as alternatives in high-risk patients.
This review highlights the rapidly expanding armamentarium of transcatheter devices for treating tricuspid regurgitation in high-risk patients.
Answers are grounded in this paper and cite their sources.
May aid decision-making in high-risk tricuspid regurgitation; leaves open need for randomized outcome trials.
Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge repair is the most widely adopted approach, while replacement technologies are advancing rapidly and offer the potential for near-complete elimination of regurgitation. In parallel, annuloplasty, spacers, and caval devices are broadening the therapeutic spectrum across diverse anatomies. This review outlines the expanding device armamentarium and the key opportunities and challenges in this evolving field.
No takes yet. Share an insight, caveat, or question.
Estevez-Loureiro et al. (2025) studied this question. Transcatheter tricuspid valve interventions, particularly edge-to-edge repair, provide a valuable treatment alternative for high-risk patients with tricuspid regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: